Clinical trials
Death clinical trials
Below are recruiting death clinical trials, each written for real people, not researchers. We’re tracking 154 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06693817Recruiting
Wireless sensors for newborns in the delivery room
This trial tests advanced wireless sensors to monitor babies born at 35 weeks or later who are stable at delivery. The goal is to see if these sensors can improve care right after birth.
Londrina, ParanáAges 8 months–10 months - NCT06739239Recruiting
French cohort study of an extra-vascular ICD
This study follows patients who receive a new type of implantable defibrillator that sits outside the heart and blood vessels. It aims to collect information about how well the device works and how safe it is over time.
ParisAges Any age - NCT06804499Recruiting
Coronary artery disease and sudden cardiac arrest study
This study is for people with coronary artery disease (blocked arteries in the heart) who live in the Pirkanmaa area of Finland. It will collect information and blood samples to better understand heart disease and sudden cardiac arrest.
Tampere, PirkanmaaAges 18 years+ - NCT06856993Recruiting
Study of early risk signs after sudden death
This study looks at tiny particles in the blood (exosomes) to see if they can help predict how patients do after a sudden collapse. The goal is to better understand who might recover and how to improve their care.
Nanjing, JiangsuAges 18 years+ - NCT06910176Recruiting
Confirming and notifying death study
This study looks at how medical students confirm and notify death. If you are a DFASM3 student at the University of Strasbourg who just took the ECOS, it may help improve training.
StrasbourgAges 18 years+ - NCT07137936Recruiting
Heart MRI Scar Study to Predict Sudden Cardiac Arrest Risk
This study uses a special heart MRI to look at scar tissue after a heart attack and see if it can help predict who might need a device to prevent sudden cardiac arrest. It is for people who had a heart attack at least a month ago and had a cardiac MRI at Anzhen Hospital.
BeijingAges 18–80 - NCT07201480Recruiting
Thinking about death and emotions: a lab study
This study looks at how thinking about death affects feelings of anxiety and sadness. You'll do a short lab task and answer questions.
Cluj-NapocaAges 18–65 - NCT00733590Recruiting
Study after ICD generator replacement for heart attack patients
This study follows people who had a prior heart attack and later received a replacement ICD (a device that helps prevent sudden dangerous heart rhythms). It is observational, meaning it mainly looks at outcomes and device-related information rather than testing a new drug.
Washington D.C., District of ColumbiaAges 18–85 - NCT00181233Recruiting
MRI imaging to assess sudden heart risk factors
This study tests heart imaging (using MRI) to better identify factors linked to sudden cardiac death risk. You may be eligible if you have reduced heart pumping ability and are planning a specific heart device to prevent dangerous heart rhythms.
Baltimore, MarylandAges 18 years+ - NCT02845531RecruitingPhase 4
Defibrillator device vs medicines for a rare heart spasm after arrest
This trial compares an implantable defibrillator device plus best care versus best medicines alone in people who survived a cardiac arrest caused by a specific abnormal heart rhythm. It focuses on variant angina, where a heart-spasm problem can trigger dangerous rhythm events, to see which approach prevents future events.
Bucheon-siAges 18 years+ - NCT07405710Recruiting
Screening older adults' medical records for code status preferences
This study looks at a tool in electronic medical records to help doctors and patients talk about life-sustaining treatment preferences. If you're an older adult who can make decisions and isn't in the ICU, you may help improve how these conversations happen.
New Brunswick, New JerseyAges 65 years+ - NCT07472153RecruitingPhase 2/Phase 3
Immunotherapy plus chemo for advanced cervical cancer
This trial tests adding immunotherapy drugs (PD-1 or PD-L1 inhibitors) to standard chemotherapy, with or without bevacizumab, for people with cervical cancer that has spread, persisted, or come back after treatment. The goal is to see which combination works better.
Minsk, LesnoyAges 18–75 - NCT07144280RecruitingPhase 3
Study of a new drug vs docetaxel for advanced lung cancer
This trial tests a new experimental drug called PF-08046054/SGN-PDL1V against a standard chemotherapy (docetaxel) for people with a type of advanced lung cancer that has PD-L1 protein on at least 1% of tumor cells and has progressed after prior treatments. The goal is to see if the new drug works better or has fewer side effects.
Alabaster, AlabamaAges 18 years+ - NCT06361303Recruiting
SNOO smart sleeper study for infant safety
This study is looking at how well the SNOO smart sleeper helps keep babies safe during sleep. If you have or plan to use a SNOO and your baby has certain risk factors, you may be able to join.
Los Angeles, CaliforniaAges 18 years+ - NCT07751432Enrolling by invitation
Improving pregnancy care in a changing climate
This study works with clinics in Dar es Salaam, Tanzania to improve pregnancy care for women living in a city, especially as the climate changes. The goal is to help keep mothers and babies healthier.
Dar es Salaam, Temeke DistrictAges 18 years+ - NCT07531095RecruitingPhase 1
Combination drug trial for small cell lung cancer
This study tests three experimental drugs (tarlatamab, ZL-1310, and sometimes an immune-boosting drug) together to treat small cell lung cancer. The goal is to see if this combination can slow or shrink the cancer and help you live longer.
Goodyear, ArizonaAges 18–99 - NCT06136260Recruiting
Grief support study for parents after child's sudden death
This study offers two types of support for parents or caregivers grieving the unexpected or traumatic death of a child under 25. It compares which approach works best in helping families cope with their loss.
Chicago, IllinoisAges 18 years+ - NCT05953558Recruiting
Study of Micra AV heart device timing in French patients
This study looks at how well a Micra AV heart device helps coordinate the heart’s timing. If you already received the Micra AV, you may be able to join as long as you consent.
ParisAges 18–110 - NCT02766166Recruiting
Study of health status scores in monitored hospital patients
This study looks at how a “health score” measures a patient’s condition and outcomes while they are in the hospital with heart monitoring. It may help doctors better assess risk and track how patients do over time.
Indianapolis, IndianaAges 18 years+ - NCT06327945Recruiting
Lung transplant from donors after circulatory death
This trial tests if lungs from donors whose hearts have stopped can be safely transplanted into people waiting for a lung transplant. It may expand the number of available donor lungs.
New York, New YorkAges 18 years+ - NCT03736889RecruitingPhase 2
Tislelizumab for MSI-H or dMMR solid tumors after prior treatment
This trial studies tislelizumab, an immune treatment that blocks PD-1, in people with MSI-H or dMMR solid tumors that cannot be fully removed or have spread, after other treatment has already been tried. It may help your immune system recognize and fight the cancer.
Hefei, AnhuiAges 18 years+ - NCT06089109Recruiting
Helping students prevent violence-related maternal deaths
This trial trains students in helping professions to support people at risk of violence during pregnancy. The goal is to reduce pregnancy-related deaths.
Lexington, KentuckyAges 18–30 - NCT05678699Recruiting
Medicaid policy study to improve maternal care equity
This study examines how Medicaid policy changes affect racial equity in severe maternal health complications and deaths. Instead of recruiting individual patients, researchers will use existing healthcare and program data from people who use Medicaid and from healthcare systems in Pennsylvania.
Pittsburgh, PennsylvaniaAges Any age - NCT02168088Recruiting
Study tissues to understand causes of sudden deaths
This trial collects and studies medical information and tissue from people who died suddenly with no clear cause, aiming to better identify hidden heart- and clot-related causes. It may help researchers improve how sudden deaths are investigated in the future.
La Jolla, CaliforniaAges Up to 45 years
Hear when a new Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for death?
- Yes. Clin2 currently lists 154 recruiting death studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a death trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a death trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.